Literature DB >> 20124056

The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery.

Jason M Sansone1, Alejandro Munoz del Rio, Paul A Anderson.   

Abstract

BACKGROUND: Venous thromboembolic disease, including deep venous thrombosis and pulmonary embolism, is a serious and potentially life-threatening complication following orthopaedic surgical procedures. We sought to investigate the prevalence of thromboembolism as well as the efficacy and complications of various prophylactic measures in a population of patients who had undergone elective spine surgery.
METHODS: A meta-analysis and univariate logistic regression were performed on selected studies to determine the prevalence of and risk factors for deep venous thrombosis and pulmonary embolism following elective spine surgery. Studies were included on the basis of the selection criteria (specifically, the inclusion of only patients undergoing spine surgery, or the treatment of patients undergoing spine surgery as an independent cohort; the use of an objective diagnostic modality for the diagnosis of deep venous thrombosis, including Doppler ultrasonography or venography; the use of an objective diagnostic modality for the diagnosis of pulmonary embolism, including computed tomography of the chest or a ventilation-perfusion scan; and a study population of more than thirty patients). Patients with a known spinal cord injury were excluded.
RESULTS: Fourteen studies (including a total of 4383 patients) met our selection criteria. On the basis of the meta-analysis, the prevalence of deep venous thrombosis was 1.09% (95% confidence interval, 0.54% to 1.64%) and the prevalence of pulmonary embolism was 0.06% (95% confidence interval, 0.01% to 0.12%) following elective spine surgery. The use of pharmacologic prophylaxis significantly reduced the prevalence of deep venous thrombosis relative to either mechanical prophylaxis (p = 0.047) or no prophylaxis (p < 0.01). One fatal pulmonary embolism was reported. An epidural hematoma requiring surgical evacuation was reported in eight of 2071 patients receiving pharmacologic prophylaxis; three of these patients had a permanent neurologic deficit.
CONCLUSIONS: The risk of deep venous thrombosis and pulmonary embolism is relatively low following elective spine surgery, particularly for patients who receive pharmacologic prophylaxis. Unfortunately, pharmacologic prophylaxis exposes patients to a greater risk of epidural hematoma. More evidence is needed prior to establishing a protocol for prophylaxis against venous thromboembolic disease in patients undergoing elective spine surgery. Future prospective studies should seek to define the safety of various prophylactic modalities and to identify specific subpopulations of patients who are at greater risk for venous thromboembolism.

Entities:  

Mesh:

Year:  2010        PMID: 20124056     DOI: 10.2106/JBJS.H.01815

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  20 in total

1.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Efficacy of ankle-brachial index as a preoperative screening in spine surgery.

Authors:  Masaru Tanaka; Fumihiro Oha; Masahiro Kanayama; Akira Iwata; Tomoyuki Hashimoto; Kazuo Kaneko
Journal:  Eur Spine J       Date:  2015-07-03       Impact factor: 3.134

Review 3.  Critical care of obese patients during and after spine surgery.

Authors:  Hossein Elgafy; Ryan Hamilton; Nicholas Peters; Daniel Paull; Ali Hassan
Journal:  World J Crit Care Med       Date:  2016-02-04

4.  Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.

Authors:  M C Fang; J Maselli; J D Lurie; P K Lindenauer; P S Pekow; A D Auerbach
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

5.  A predictive model of preoperative risk factors for venous thromboembolism after fusion for degenerative conditions of the thoracolumbar spine.

Authors:  McKayla Kelly; Alessandro Speciale; Chad Patton; Justin Turcotte
Journal:  J Orthop       Date:  2020-11-19

6.  Modifiable Patient Factors Demonstrate No Increased Risk for 30-Day Complication Rate for Elective 1-2 Level Posterior Lumbar Fusion Surgery: A Comparison Between a National Database and Local Registry.

Authors:  Cameron Kia; Aris Yannopoulos; Sagar Gulati; Michael Cremins; Mark Cote; Isaac Moss
Journal:  Int J Spine Surg       Date:  2022-07-14

7.  Thrombophilic abnormalities in patients with or without pulmonary embolism following elective spinal surgery: a pilot study.

Authors:  Suhel Kotwal; Satoshi Kawaguchi; Alexander Hughes; Frank Cammisa; Kai Zhang; Eduardo Salvati; Federico Girardi
Journal:  HSS J       Date:  2013-01-24

8.  Venous Thromboembolism After Degenerative Spine Surgery: A Nationwide Readmissions Database Analysis.

Authors:  Ian A Buchanan; Michelle Lin; Daniel A Donoho; Li Ding; Steven L Giannotta; Frank Attenello; William J Mack; John C Liu
Journal:  World Neurosurg       Date:  2019-01-23       Impact factor: 2.104

9.  Risk factors for venous thromboembolism after spine surgery.

Authors:  Hiroyuki Tominaga; Takao Setoguchi; Fumito Tanabe; Ichiro Kawamura; Yasuhiro Tsuneyoshi; Naoya Kawabata; Satoshi Nagano; Masahiko Abematsu; Takuya Yamamoto; Kazunori Yone; Setsuro Komiya
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

10.  II Italian intersociety consensus statement on antithrombotic prophylaxis in orthopaedics and traumatology: arthroscopy, traumatology, leg immobilization, minor orthopaedic procedures and spine surgery.

Authors:  F Randelli; E Romanini; F Biggi; G Danelli; G Della Rocca; N R Laurora; D Imberti; G Palareti; D Prisco
Journal:  J Orthop Traumatol       Date:  2012-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.